Literature DB >> 9746593

Antigenic analysis of Bordetella pertussis filamentous hemagglutinin with phage display libraries and rabbit anti-filamentous hemagglutinin polyclonal antibodies.

D R Wilson1, A Siebers, B B Finlay.   

Abstract

Although substantial advancements have been made in the development of efficacious acellular vaccines against Bordetella pertussis, continued progress requires better understanding of the antigenic makeup of B. pertussis virulence factors, including filamentous hemagglutinin (FHA). To identify antigenic regions of FHA, phage display libraries constructed by using random fragments of the 10-kbp EcoRI fragment of B. pertussis fhaB were affinity selected with rabbit anti-FHA polyclonal antibodies. Characterization of antibody-reactive clones displaying FHA-derived peptides identified 14 antigenic regions, each containing one or more epitopes. A number of clones mapped within regions containing known or putative FHA adhesin domains and may be relevant for the generation of protective antibodies. The immunogenic potential of the phage-displayed peptides was assessed indirectly by comparing their recognition by antibodies elicited by sodium dodecyl sulfate (SDS)-denatured and native FHA and by measuring the inhibition of this recognition by purified FHA. FHA residues 1929 to 2019 may contain the most dominant linear epitope of FHA. Clones mapping to this region accounted for ca. 20% of clones recovered from the initial library selection and screening procedures. They are strongly recognized by sera against both SDS-denatured and native FHA, and this recognition is readily inhibited by purified FHA. Given also that this region includes a factor X homolog (J. Sandros and E. Tuomanen, Trends Microbiol. 1:192-196, 1993) and that the single FHA epitope (residues 2001 to 2015) was unequivocally defined in a comparable study by E. Leininger et al. (J. Infect. Dis. 175:1423-1431, 1997), peptides derived from residues of 1929 to 2019 of FHA are strong candidates for future protection studies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9746593      PMCID: PMC108604     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

1.  Methods and algorithms for statistical analysis of protein sequences.

Authors:  V Brendel; P Bucher; I R Nourbakhsh; B E Blaisdell; S Karlin
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

2.  Interaction of the Bordetella pertussis filamentous hemagglutinin with heparin.

Authors:  F D Menozzi; C Gantiez; C Locht
Journal:  FEMS Microbiol Lett       Date:  1991-02       Impact factor: 2.742

3.  The multicenter acellular pertussis trial: an overview.

Authors:  M D Decker; K M Edwards
Journal:  J Infect Dis       Date:  1996-11       Impact factor: 5.226

4.  Immunodominant domains present on the Bordetella pertussis vaccine component filamentous hemagglutinin.

Authors:  E Leininger; S Bowen; G Renauld-Mongénie; J H Rouse; F D Menozzi; C Locht; I Heron; M J Brennan
Journal:  J Infect Dis       Date:  1997-06       Impact factor: 5.226

5.  Genomic fluidity of Bordetella pertussis assessed by a new method for chromosomal mapping.

Authors:  S Stibitz; M S Yang
Journal:  J Bacteriol       Date:  1997-09       Impact factor: 3.490

Review 6.  Environmental regulation of virulence factors in Bordetella species.

Authors:  V Scarlato; B Aricó; M Domenighini; R Rappuoli
Journal:  Bioessays       Date:  1993-02       Impact factor: 4.345

7.  Surface display and peptide libraries. Cold Spring Harbor Laboratory, April 4-7, 1992. Proceedings.

Authors: 
Journal:  Gene       Date:  1993-06-15       Impact factor: 3.688

Review 8.  Pathogenicity mechanisms of Bordetella.

Authors:  R Rappuoli
Journal:  Curr Top Microbiol Immunol       Date:  1994       Impact factor: 4.291

9.  Inhibition of leukocyte-endothelial cell interactions and inflammation by peptides from a bacterial adhesin which mimic coagulation factor X.

Authors:  E Rozdzinski; J Sandros; M van der Flier; A Young; B Spellerberg; C Bhattacharyya; J Straub; G Musso; S Putney; R Starzyk
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

10.  Amino-terminal maturation of the Bordetella pertussis filamentous haemagglutinin.

Authors:  F Jacob-Dubuisson; C Buisine; N Mielcarek; E Clément; F D Menozzi; C Locht
Journal:  Mol Microbiol       Date:  1996-01       Impact factor: 3.501

View more
  6 in total

1.  Fusion expression and immunogenicity of Bordetella pertussis PTS1-FHA protein: implications for the vaccine development.

Authors:  Zhang Jinyong; Zhang Xiaoli; Zhang Weijun; Guo Ying; Guo Gang; Mao Xuhu; Zou Quanming
Journal:  Mol Biol Rep       Date:  2010-09-28       Impact factor: 2.316

2.  Haemagglutination induced by Bordetella pertussis filamentous haemagglutinin adhesin (FHA) is inhibited by antibodies produced against FHA(430-873) fragment expressed in Lactobacillus casei.

Authors:  Débora Colombi; Maria L S Oliveira; Ivana B Campos; Vicente Monedero; Gaspar Pérez-Martinez; Paulo L Ho
Journal:  Curr Microbiol       Date:  2006-11-13       Impact factor: 2.188

3.  Natural-host animal models indicate functional interchangeability between the filamentous haemagglutinins of Bordetella pertussis and Bordetella bronchiseptica and reveal a role for the mature C-terminal domain, but not the RGD motif, during infection.

Authors:  Steven M Julio; Carol S Inatsuka; Joseph Mazar; Christine Dieterich; David A Relman; Peggy A Cotter
Journal:  Mol Microbiol       Date:  2009-02-10       Impact factor: 3.501

4.  Eighty-kilodalton N-terminal moiety of Bordetella pertussis filamentous hemagglutinin: adherence, immunogenicity, and protective role.

Authors:  Sylvie Alonso; Nathalie Reveneau; Kévin Pethe; Camille Locht
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

5.  Subcutaneous vaccination with attenuated Salmonella enterica serovar Choleraesuis C500 expressing recombinant filamentous hemagglutinin and pertactin antigens protects mice against fatal infections with both S. enterica serovar Choleraesuis and Bordetella bronchiseptica.

Authors:  Zhanqin Zhao; Yun Xue; Bin Wu; Xibiao Tang; Ruiming Hu; Yindi Xu; Aizhen Guo; Huanchun Chen
Journal:  Infect Immun       Date:  2008-02-11       Impact factor: 3.441

6.  Expression, Purification and Characterization of Three Overlapping Immunodominant Recombinant Fragments from Bordetella pertussis Filamentous Hemagglutinin.

Authors:  Hossein Asgarian-Omran; Ali Akbar Amirzargar; Mohammad Arjmand; Mohammadreza Eshraghian; Behrooz Nikbin; Saeid Eshraghi; Marzieh Mahdavi; Jalal Khoshnoodi; Mahmood Jeddi-Tehrani; Hodjatallah Rabbani; Fazel Shokri
Journal:  Avicenna J Med Biotechnol       Date:  2013-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.